Login / Signup

Chimeric antigen receptors: "CARs" in the fast lane for rheumatology.

Nathan M JohnsonFotios Koumpouras
Published in: Current opinion in rheumatology (2024)
CAR-T treatment has shown striking drug-free responses in severe lupus and other autoimmune diseases, creating a need for further exploration and development.
Keyphrases
  • systemic lupus erythematosus
  • cell therapy
  • early onset
  • disease activity
  • drug induced
  • emergency department
  • rheumatoid arthritis
  • combination therapy
  • mesenchymal stem cells
  • adverse drug